Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Sectra

BATS-CHIXE:SECTBS
Snowflake Description

Flawless balance sheet with outstanding track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SECTBS
BATS-CHIXE
SEK15B
Market Cap
  1. Home
  2. GB
  3. Healthcare
Company description

Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
SECTBS Share Price and Events
7 Day Returns
4.1%
BATS-CHIXE:SECTBS
-1.2%
GB Medical Equipment
0.1%
GB Market
1 Year Returns
36.2%
BATS-CHIXE:SECTBS
-0.3%
GB Medical Equipment
-23.6%
GB Market
SECTBS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Sectra (SECTBS) 4.1% -4.5% -3.4% 36.2% 139.7% 218%
GB Medical Equipment -1.2% -12% -19.1% -0.3% -2.3% 20.9%
GB Market 0.1% -15.5% -27% -23.6% -24.3% -23.5%
1 Year Return vs Industry and Market
  • SECTBS outperformed the Medical Equipment industry which returned -0.3% over the past year.
  • SECTBS outperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -23.6% over the past year.
Price Volatility
SECTBS
Industry
5yr Volatility vs Market

Value

 Is Sectra undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Sectra to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Sectra.

BATS-CHIXE:SECTBS Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2020-01-31) in SEK SEK 4.8333333333333
Payout Ratio Company Filings (2020-01-31) 0%
Discount Rate (Cost of Equity) See below 5.5%
Perpetual Growth Rate 10-Year GB Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BATS-CHIXE:SECTBS
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 5.4%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.81
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.808 (1 + (1- 22%) (0.58%))
0.907
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.91
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.53% + (0.907 * 5.44%)
5.46%

Discounted Cash Flow Calculation for BATS-CHIXE:SECTBS using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Sectra is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

BATS-CHIXE:SECTBS Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= SEK4.83 / (5.46% - 0.53%)
SEK96.23
BATS-CHIXE:SECTBS Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BATS-CHIXE:SECTBS represents 0.99109x of OM:SECT B
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99109x
Value per Share
(Listing Adjusted, SEK)
= Value per Share (SEK) x Listing Adjustment Factor
= SEK 97.97 x 0.99109
SEK97.09
Value per share (SEK) From above. SEK97.09
Current discount Discount to share price of SEK389.50
= -1 x (SEK389.50 - SEK97.09) / SEK97.09
-301.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Sectra is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Sectra's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Sectra's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:SECTBS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2020-01-31) in SEK SEK5.95
OM:SECT B Share Price ** OM (2020-04-07) in SEK SEK393
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PE Ratio Median Figure of 11 Publicly-Listed Medical Equipment Companies 25.55x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 12.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Sectra.

BATS-CHIXE:SECTBS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OM:SECT B Share Price ÷ EPS (both in SEK)

= 393 ÷ 5.95

66x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sectra is overvalued based on earnings compared to the GB Medical Equipment industry average.
  • Sectra is overvalued based on earnings compared to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Sectra's expected growth come at a high price?
Raw Data
BATS-CHIXE:SECTBS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 66x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
10.9%per year
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PEG Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 2x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 517 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

BATS-CHIXE:SECTBS PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 66x ÷ 10.9%

6.06x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sectra is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Sectra's assets?
Raw Data
BATS-CHIXE:SECTBS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2020-01-31) in SEK SEK18.81
OM:SECT B Share Price * OM (2020-04-07) in SEK SEK393
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PB Ratio Median Figure of 20 Publicly-Listed Medical Equipment Companies 2.83x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.11x
BATS-CHIXE:SECTBS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OM:SECT B Share Price ÷ Book Value per Share (both in SEK)

= 393 ÷ 18.81

20.89x

* Primary Listing of Sectra.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sectra is overvalued based on assets compared to the GB Medical Equipment industry average.
X
Value checks
We assess Sectra's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Sectra has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Sectra expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Sectra expected to grow at an attractive rate?
  • Sectra's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Sectra's earnings growth is positive but not above the United Kingdom of Great Britain and Northern Ireland market average.
  • Sectra's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:SECTBS Future Growth Rates Data Sources
Data Point Source Value (per year)
BATS-CHIXE:SECTBS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 10.9%
BATS-CHIXE:SECTBS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 8.6%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.1%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.5%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:SECTBS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in SEK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:SECTBS Future Estimates Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-04-30 1,986 296 285 2
2021-04-30 1,810 283 251 2
2020-04-30 1,652 294 227 2
2020-04-07
BATS-CHIXE:SECTBS Past Financials Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income *
2020-01-31 1,673 285 229
2019-10-31 1,541 231 190
2019-07-31 1,492 207 196
2019-04-30 1,451 251 199
2019-01-31 1,299 267 186
2018-10-31 1,270 233 181
2018-07-31 1,267 199 189
2018-04-30 1,237 208 185
2018-01-31 1,246 181 166
2017-10-31 1,237 240 166
2017-07-31 1,203 242 151
2017-04-30 1,170 235 153

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Sectra's earnings are expected to grow by 10.9% yearly, however this is not considered high growth (20% yearly).
  • Sectra's revenue is expected to grow by 8.6% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:SECTBS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Sectra Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:SECTBS Future Estimates Data
Date (Data in SEK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-04-30 7.39 7.41 7.38 2.00
2021-04-30 6.51 6.53 6.48 2.00
2020-04-30 5.88 6.03 5.73 2.00
2020-04-07
BATS-CHIXE:SECTBS Past Financials Data
Date (Data in SEK Millions) EPS *
2020-01-31 5.95
2019-10-31 4.95
2019-07-31 5.14
2019-04-30 5.21
2019-01-31 4.87
2018-10-31 4.74
2018-07-31 4.96
2018-04-30 4.86
2018-01-31 4.38
2017-10-31 4.38
2017-07-31 3.98
2017-04-30 4.04

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Sectra is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Sectra's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Sectra has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Sectra performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Sectra's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Sectra's year on year earnings growth rate has been positive over the past 5 years.
  • Sectra's 1-year earnings growth exceeds its 5-year average (23% vs 13%)
  • Sectra's earnings growth has exceeded the GB Medical Equipment industry average in the past year (23% vs -9.5%).
Earnings and Revenue History
Sectra's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Sectra Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:SECTBS Past Revenue, Cash Flow and Net Income Data
Date (Data in SEK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2020-01-31 1,672.87 228.53 266.99
2019-10-31 1,541.31 189.69 259.05
2019-07-31 1,491.66 196.45 250.35
2019-04-30 1,450.79 198.98 240.58
2019-01-31 1,299.32 185.86 232.84
2018-10-31 1,270.30 180.62 236.05
2018-07-31 1,266.74 188.79 233.05
2018-04-30 1,237.41 184.71 222.44
2018-01-31 1,246.21 166.07 223.28
2017-10-31 1,237.30 166.01 214.43
2017-07-31 1,203.09 150.76 208.71
2017-04-30 1,170.29 152.57 205.25
2017-01-31 1,149.16 137.25 198.22
2016-10-31 1,128.63 131.05 207.40
2016-07-31 1,113.99 123.29 211.26
2016-04-30 1,107.40 125.70 217.79
2016-01-31 1,058.75 117.00 215.69
2015-10-31 1,030.67 116.51 196.24
2015-07-31 1,006.97 118.72 184.81
2015-04-30 993.57 126.08 172.22
2015-01-31 989.09 129.61 164.24
2014-10-31 946.33 130.02 157.96
2014-07-31 904.59 126.12 155.27
2014-04-30 870.11 103.86 154.21
2014-01-31 849.54 93.09 143.65
2013-10-31 847.33 82.13 148.22
2013-07-31 839.71 73.87 146.79
2013-04-30 829.16 62.25 153.63

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Sectra has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Sectra used its assets more efficiently than the GB Medical Equipment industry average last year based on Return on Assets.
  • Sectra has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Sectra's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Sectra has a total score of 6/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Sectra's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Sectra's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Sectra is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Sectra's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Sectra's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 301.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Sectra Company Filings, last reported 2 months ago.

BATS-CHIXE:SECTBS Past Debt and Equity Data
Date (Data in SEK Millions) Total Equity Total Debt Cash & Short Term Investments
2020-01-31 724.27 2.95 304.09
2019-10-31 617.44 6.45 189.44
2019-07-31 741.27 6.45 271.19
2019-04-30 727.91 31.48 331.94
2019-01-31 563.97 6.45 265.92
2018-10-31 490.45 29.39 190.61
2018-07-31 613.40 28.53 291.97
2018-04-30 660.95 56.61 282.34
2018-01-31 500.97 28.53 195.78
2017-10-31 446.30 56.61 150.04
2017-07-31 561.61 56.61 278.00
2017-04-30 541.41 77.59 273.22
2017-01-31 487.79 56.61 221.64
2016-10-31 442.02 50.10 111.62
2016-07-31 579.05 50.10 248.05
2016-04-30 545.60 75.02 239.77
2016-01-31 515.40 52.57 199.20
2015-10-31 510.41 37.97 133.09
2015-07-31 663.03 37.97 302.35
2015-04-30 611.78 55.91 307.08
2015-01-31 568.66 46.94 250.64
2014-10-31 531.10 28.43 313.20
2014-07-31 664.81 28.43 462.89
2014-04-30 611.70 43.49 441.95
2014-01-31 567.25 37.40 443.54
2013-10-31 534.05 27.17 394.31
2013-07-31 676.38 20.41 513.01
2013-04-30 665.30 26.50 536.29
  • Sectra's level of debt (0.4%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (8.3% vs 0.4% today).
  • Debt is well covered by operating cash flow (9674.2%, greater than 20% of total debt).
  • Sectra earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess Sectra's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Sectra has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Sectra's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Sectra dividends. Estimated to be 1.23% next year.
If you bought SEK2,000 of Sectra shares you are expected to receive SEK0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Sectra's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Sectra's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:SECTBS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2.2%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.6%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.6%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:SECTBS Future Dividends Estimate Data
Date (Data in SEK) Dividend per Share (annual) Avg. No. Analysts
2022-04-30 5.00 2.00
2021-04-30 4.75 2.00
2020-04-30 4.75 2.00
2020-04-07
BATS-CHIXE:SECTBS Past Annualized Dividends Data
Date (Data in SEK) Dividend per share (annual) Avg. Yield (%)
2010-03-16 0.000 0.000
2009-12-08 0.000 0.000
2009-09-14 0.000 0.000
2009-06-12 0.000 0.000
2009-05-26 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Sectra has not reported any payouts.
  • Unable to verify if Sectra's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Sectra's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Sectra has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Sectra's dividends in 3 years as they are not expected to pay a notable one for United Kingdom of Great Britain and Northern Ireland.
X
Income/ dividend checks
We assess Sectra's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Sectra afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Sectra has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Sectra's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Torbjörn Kronander
COMPENSATION SEK3,700,000
AGE 62
TENURE AS CEO 7.4 years
CEO Bio

Dr. Torbjörn Kronander, Ph.D., MBA, has been the Chief Executive Officer and President of Sectra Aktiebolag (publ) since November 1, 2012 and also serves as its Director since 1988. Dr. Kronander has also been the President of Sectra Imtec AB, a subsidiary of Sectra AB since 1997. He served as the Executive Vice President of Sectra AB until November 1, 2012. He served as a Vice President at Sectra AB since 1997. He has been a Director of Sectra Aktiebolag (publ) since 1988. Dr. Kronander serves as a Board Member of Bäver & Nilsson AB. He was Director at CellaVision AB till May 8, 2019.

CEO Compensation
  • Torbjörn's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Torbjörn's remuneration is lower than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the Sectra management team in years:

7.3
Average Tenure
49.5
Average Age
  • The average tenure for the Sectra management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Torbjörn Kronander

TITLE
President
COMPENSATION
SEK4M
AGE
62
TENURE
7.4 yrs

Robert Forchheimer

TITLE

Viiveke Fåk

TITLE

Ingemar Ingemarsson

TITLE

Mats Franzén

TITLE
Chief Financial Officer
AGE
50
TENURE
4.3 yrs

Fredrik Gustavsson

TITLE
Chief Technology Officer

Helena Pettersson

TITLE
Chief Investor Relations Officer
AGE
49

Lisa Everhill

TITLE
Chief People & Brand Officer
AGE
40

Simo Pykälistö

TITLE
President of Secure Communications Operating Area & Executive VP
AGE
47
TENURE
7.3 yrs

Marie Tragardh

TITLE
President of Imaging IT Solutions Business Area
AGE
58
TENURE
7.3 yrs
Board of Directors Tenure

Average tenure and age of the Sectra board of directors in years:

4.3
Average Tenure
60
Average Age
  • The tenure for the Sectra board of directors is about average.
Board of Directors

Jan-Olof Brüer

TITLE
Chairman of the Board
COMPENSATION
SEK402K
AGE
68
TENURE
1.6 yrs

Torbjörn Kronander

TITLE
President
COMPENSATION
SEK4M
AGE
62
TENURE
32.3 yrs

Christer Nilsson

TITLE
Independent Director
COMPENSATION
SEK292K
AGE
67
TENURE
12.3 yrs

Anders Persson

TITLE
Independent Director
COMPENSATION
SEK265K
AGE
66
TENURE
16.3 yrs

Deborah Capello

TITLE
Employee Representative Director
AGE
49
TENURE
6.3 yrs

Bengt Hellman

TITLE
Employee Representative Director
AGE
39
TENURE
5.3 yrs

Tomas Puusepp

TITLE
Independent Director
COMPENSATION
SEK225K
AGE
64
TENURE
3.3 yrs

Birgitta Hagenfeldt

TITLE
Independent Director
COMPENSATION
SEK177K
AGE
58
TENURE
1.6 yrs

Jonas Yngvesson

TITLE
Independent Director
AGE
54
TENURE
0.6 yrs

Filip Klintenstedt

TITLE
Deputy Employee Representative Board Member
AGE
38
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • Sectra individual insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (SEK) Value (SEK)
10. Mar 20 Sell Marie Tragardh Individual 06. Mar 20 09. Mar 20 -1,940 SEK415.79 SEK-800,561
05. Mar 20 Buy Birgitta Hagenfeldt Individual 04. Mar 20 05. Mar 20 1,000 SEK410.25 SEK409,338
01. Oct 19 Buy Simo Pykälistö Individual 01. Oct 19 01. Oct 19 250 SEK328.00 SEK82,000
04. Sep 19 Buy Per Andersnäs Individual 03. Sep 19 03. Sep 19 150 SEK307.50 SEK46,075
X
Management checks
We assess Sectra's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Sectra has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company’s Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society’s sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society’s critical operations. The company’s Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in Linköping, Sweden.

Details
Name: Sectra AB (publ)
SECTBS
Exchange: BATS-CHIXE
Founded: 1978
SEK15,152,118,870
38,506,020
Website: http://www.sectra.com
Address: Sectra AB (publ)
Teknikringen 20,
Linköping,
Östergötland County, 583 30,
Sweden
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OM SECT B Series B Shares OMX Nordic Exchange Stockholm SE SEK 03. Mar 1999
LSE 0A0L Series B Shares London Stock Exchange GB SEK 03. Mar 1999
BATS-CHIXE SECTBS Series B Shares BATS 'Chi-X Europe' GB SEK 03. Mar 1999
Number of employees
Current staff
Staff numbers
774
Sectra employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 20:35
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/03/20
Last earnings filing: 2020/03/04
Last earnings reported: 2020/01/31
Last annual earnings reported: 2019/04/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.